Fca Health Innovations Ii Management LLCFirm match from fund name (lower confidence)
FCA Health Innovations III AI, LP
RaisingEmerging manager
Raising: Form D filed May 2026 reports amount sold below target
- Vintage
- 2026
- Fund size
- $3.1M to $175M (Form D)
- Stages
- Seed, Series A, Series B
- Sectors
- AI applications
- Regions
- Not stated
01 · Thesis
Invests in healthcare companies transforming care through innovative technology and services across providers, payers, pharma, and innovative care delivery. Focuses on seed and Series A/B companies with 50%+ annual growth.Inferred from the firm's website
02 · Initial check
$31K to $2.92M (estimated from fund size)
Estimated from Form D: $3.1M sold of a $175M target
03 · Who to approach
Named on this fund's Form D
- Andrew Bouldin, Managing Partner
- Matt King, Managing Partner
- Whitney Kalb, Partner & General Counsel
- Charles Johnson, Manager of the Manager of the General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideFCA Venture Partners invests in companies transforming healthcare through innovative technology and services.
FCA Venture Partners invests in companies transforming healthcare through innovative technology and services.
https://www.fcavp.com/strategy
06 · Sources
Last verified: Oct 28, 2026